Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
ACS Macro Letters|March 10, 2020
Multivalent Polymer-Peptide Conjugates-A General Platform for Inhibiting Amyloid Beta Peptide AggregationXing Jiang, Abigail J Halmes, Giuseppe Licari, et al.ACS Applied Nano Materials|March 10, 2020
Polymer-Peptide Conjugates Convert Amyloid into Protein Nanobundles through Fragmentation and Lateral AssociationJohn W Smith, Xing Jiang, Hyosung An, et al.Science Advances|February 23, 2022
Mechanism and performance relevance of nanomorphogenesis in polyamide films revealed by quantitative 3D imaging and machine learningHyosung An, John W Smith, Bingqiang Ji, et al.Seminars in Oncology|February 24, 2005
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensificationSteven K Seung, John W Smith, John Molendyk, et al.Breast Cancer Research and Treatment|October 30, 2013
Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patientsJohn W Smith, Svetislava Vukelja, Amy Rabe, et al.Advanced Materials (Deerfield Beach, Fla.)|January 8, 2024
Highly Ordered Eutectic Mesostructures via Template-Directed Solidification within Thermally Engineered TemplatesSung Bum Kang, Guanglong Huang, Gaurav Singhal, et al.Nature Communications|April 11, 2024
Beyond nothingness in the formation and functional relevance of voids in polymer filmsFalon C Kalutantirige, Jinlong He, Lehan Yao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta2-microglobulin gene-modified autologous tumor cellsSybren L Meijer, Annemieke Dols, Walter J Urba, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancerKim Margolin, Michael B Atkins, Janice P Dutcher, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cellsAnnemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.Pageof 5